Dana-Farber experts recommend actionable steps to enhance the rigor and transparency of FDA validation standards for radiology AI software.
Key Details
- 1The current FDA regulatory framework for SaMD validation is flexible but lacks explicit, consistent standards for radiology AI.
- 2Common radiology SaMD types include CADq, CADt, CADe, CADx, CADe/x, and CADa/o.
- 3Retrospective validation is typical for assistive radiology AI; prospective studies are standard for autonomous devices.
- 4Concerns exist over inadequate evaluation metrics for generative models and the use of synthetic data for some devices.
- 5Recommendations include removing nonclinical validation for certain devices, requiring more reader and prospective studies, adopting mandatory reporting checklists, and creating a public validation database.
Why It Matters
Clear and consistent FDA standards are crucial for ensuring the clinical reliability, performance, and reporting transparency of AI tools used in radiology, directly impacting adoption and trust among professionals and patients.
Source
AuntMinnie
Related News
•Radiology Business
UCLA Appoints Inaugural Associate Dean for Health AI Strategy
UCLA has appointed Katherine P. Andriole as its first associate dean for Health AI Strategy and Innovation, with an initial focus on radiology.
•HealthExec
EFF Sues CMS For Transparency on AI-Powered Medicare Prior Authorization
EFF has sued CMS to compel disclosure about the WISeR pilot deploying AI for Medicare prior authorization.
•Radiology Business
AI Tool Developed to Detect Domestic Violence via Radiology Data
Mass General radiologists developed a machine learning tool to identify patients at risk of intimate partner violence using imaging and clinical records.